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INTRODUCTION:  Colonic bacteria produce short-chain fatty acids (SCFAs) by 
fermentation of dietary carbohydrates and fiber. The production of SCFAs is greatest in 
proximal colon where propulsion is likely to be highly dependent on chemical/nutrient 
stimuli. Unabsorbed SCFAs entering the distal colon are likely to modify peristalsis 
initiated by fecal pellet-induced distension. AIM: To determine the effect of individual 
SCFAs on propulsive contractions in guinea pig proximal colon and on pellet propulsion in 
distal colon. METHODS: Proximal colon was excised, cannulated and placed in Krebs 
buffer in an organ bath. After equilibration, the colon was distended with 1ml of Krebs 
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buffer alone or containing sodium salts of acetate, butyrate, or propionate at 10-100mM. 
Motility was video recorded, spatiotemporal maps generated, and the number of full-length 
propulsive contractions during a 5 min period was determined. The distal colon was 
removed from guinea pig and placed in an organ bath containing Krebs buffer. Following 
equilibration, video-tracking software was used to measure the velocity of propulsion of a 
clay pellet placed in the orad end of a segment.  Krebs buffer alone or containing 
individual SCFAs at 30mM was perfused caudad to the pellet at 0.1 ml/min. RESULTS: 
The basal rate of propulsive contractions in Krebs buffer was 2.9 ± 0.7 per 5 min. Butyrate 
and propionate had concentration-dependent and opposing effects on propulsive 
contractions; acetate had no effect. Butyrate significantly increased propulsive contractions 
(maximal increase of 207% (p ≤ 0.05) at 30 mM) whereas propionate abolished propulsive 
contractions (91-100% inhibition at 10-30mM). Control Krebs buffer containing 10-
100mM NaCl had no effect. The mean rate of pellet propulsion during perfusion of Krebs 
buffer alone was 1.5 ± 0.2 mm/sec. Addition of sodium butyrate (30 mM) to the perfusate 
increased the velocity of pellet propulsion by 40 ± 4% (p<0.05) whereas addition of 30mM 
sodium propionate decreased velocity of pellet propulsion by 75 ± 8%. Acetate had no 
significant effect in either proximal or distal colon. Mixtures of SCFAs showed a general 
decrease in overall motility. CONCLUSION: SCFAs have differential effects on 
propulsive contractions in the proximal and distal colon of the guinea pig, with butyrate 
being excitatory and propionate being inhibitory. These studies suggest that the movement 
of feces in the colon depends not only on distension but the chemical (i.e. dietary) 
composition of the feces.
  1 
 
 
 
 
1. Introduction 
 
 
1. A) The Anatomy of the Gastrointestinal Tract 
 
 The gastrointestinal (GI) tract is a tubular organ that traverses the thoracic and 
abdominal cavity, beginning at the mouth, continuing through the esophagus, stomach, 
small (duodenum, jejunum, and ileum) and large (cecum and colon) intestine, into the 
rectum and finally ending at the anus. It serves two primary functions, to absorb nutrients 
from ingested food and to serve as a barrier between ingested material from the outside 
environment and the interior systems of the body.  The anatomy can be divided into two 
general structures: the muscular layers and the mucosal layer. 
 
 A1) Characteristics of the Muscular Layers 
 
 The GI tract consists of an outer longitudinal muscle layer, which is closely 
associated with the more interior circular muscle layer. Each of these muscle layers serves 
a role in mixing and propelling luminal contents in an anal (caudad) direction. The 
longitudinal layer contracts in the orad and caudad direction along the tract, while the 
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circular layer contracts and results in occlusion of the luminal space. These layers contract 
in a coordinated fashion in order to propel contents. This coordination is due to the neural 
networks that are collected in the myenteric plexus, a layer of neurons that are situated 
between the longitudinal and circular muscle. The neurons of the myenteric plexus extend 
projections into both muscle layers and release a multitude of neuropeptides and 
neurotransmitters. This complex patterning of neural release regulates the various motility 
patterns observed in the GI tract. 
 There are two primary motility patterns that are observed in the gut. The first is a 
reflex known as peristalsis, which results in the propulsion of luminal contents in a caudad 
direction by coordinated contraction of the circular muscle orad and relaxation caudad of a 
bolus in the lumen of the GI tract. (45) The second pattern of motility is known as 
segmentation, and is considered to be a non-propulsive contraction of the circular muscle 
layer in order to mix luminal contents to facilitate more effective digestion and absorption 
of luminal contents. (47) (Figure 1A) 
 
A2) Characteristics of the Mucosal Layers 
 
 Closer to the lumen of the GI tract lies the submucosa, a layer of connective tissue 
that contains a large vascular and lymphatic network, which serves to transport nutrients 
and hormones to and from the mucosa. The mucosa is a layer of epithelial cells that are in 
direct contact with the lumen of the GI tract, and are responsible for absorption of 
nutrients. Many cells of the submucosa and mucosa are closely associated with axons of 
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neurons that lie in the submucosal plexus, which lies between the submucosa and circular 
muscle layer. This neural network receives signals from epithelial cells in the mucosal 
layer via afferent neurons that control and influence the motility patterns of the muscle 
layers by synapsing with both the muscle layers as well as the neurons of the myenteric 
plexus. (Figure 1A) 
 
 A3) The neural reflex of motility 
 
 Despite the level of diversity regarding all the neurons of the enteric nervous 
system, much work has been done to piece together the basic reflex related to peristalsis. 
(1, 43, 44, 46) (Figure 1B). Beginning on the luminal surface of the epithelium, chemical 
or physical stimulation from chyme facilitates 5-HT (serotonin) release from 
enteroendocrine cells. 5-HT activates calcitonin-gene regulated peptide (CGRP) containing 
afferent neurons in the submucosa, which then signal into the myenteric plexus. At this 
point, a series of interneurons are activated and ultimately stimulate the release of 
substance P (SP) and acetylcholine (Ach) orad and vasoactive intestinal peptide (VIP) and 
nitric oxide (NO) caudad. These molecules cause orad contraction and caudad relaxation of 
the circular muscle, respectively. (1, 43, 46) Simultaneously, the opposite muscular effect 
is observed in the longitudinal muscle layer. Together, this results in the coordination 
propulsion of luminal contents caudally through the GI tract. Distension of the intestinal 
wall is also capable of initiating peristalsis via an extrinsic afferent neuron that relays 
through the dorsal root ganglia. (46) 
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1. B) Function of the Gastrointestinal Tract 
 
 Once ingested contents exit the stomach, they are sufficiently broken down for 
further digestion and absorption in the small intestine. Proteins are efficiently broken down 
by peptidases and absorbed, and fats are emulsified with bile, digested, and absorbed into 
the lymphatic system. Simple carbohydrates are digested by amylases and absorbed 
through transporters on the surface of the epithelium. Certain compounds, such as cellulose 
and other carbohydrate chains (termed as fiber), are not digestible by the enzymes secreted 
into the lumen of the GI tract. These compounds reach the ileum and are propelled into the 
cecum through the ileocecal valve. At this point, luminal contents are condensed into feces 
and are fermented by bacteria that reside in the large intestine. These resident bacteria have 
been referred to as the microbiome. 
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Figure 1. Diagram of the GI Tract and the Canonical Pathway of the Peristaltic 
Reflex 
 
 A) The layers of the GI tract move out from the lumen to include the mucosa, 
submucosa, submucosal plexus, circular muscle layer, myenteric plexus, longitudinal 
muscle layer, and serosa. B) Either mechanical or chemical stimulation of the intestinal 
mucosa causes release of 5-HT from enteroendocrine cells. 5-HT in turn is released on the 
basolateral side and activates CGRP-containing neurons which then activate a series of 
interneurons in the myenteric plexus. These interneurons activate motor neurons, which 
release acetylcholine (Ach), tachykinin (TK), and substance P (SP, not pictured) orad to 
the luminal stimulus and cause contraction of the circular muscle and relaxation of the 
longitudinal muscle. Vasoactive intestinal peptide (VIP) and nitric oxide (NO) are released 
caudad to the luminal stimulus and stimulate circular relaxation and longitudinal 
contraction. This coordinated activity results in the caudal propulsion of luminal contents 
via peristalsis. (Yellow = Afferent Neurons; Green = Interneurons; Blue = Motor Neurons) 
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Figure 1. Diagram of GI Tract and the Canonical Pathway of the Peristaltic Reflex 
A 
B 
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 1. C) Characteristics of the Gut Microbiome 
 
 The microbiome is a massive, diverse population of commensal bacteria that reside 
on all the external body surfaces, including the vagina and colon. In the colon the 
microbiome consists of ~1000 species. (50) They are first introduced to newborns through 
the secretion of the birth canal as well as through mother’s milk (2).  This initial population 
develops in the colon of the growing organism and serves to ferment any undigested 
material, as well as provide an immunomodulatory effect in the gut and prevent pathogenic 
bacteria from growing in the anaerobic environment of the colon. (3, 48) 
The microbiome is also modified by various dietary inputs. (51, 52) The 
composition of carbohydrates and fibers within different foods has been shown to change 
the population of bacteria that make up the microbiome. (4, 51, 52, 53) Use of antibiotics 
has also been shown to severely limit the growth and diversity of bacteria in the colon. (5) 
Reductions of diversity in the microbial population have been correlated to various GI 
pathologies, such as inflammatory bowel diseases (IBDs) and irritable bowel syndrome 
(IBS). (6-9) While no specific organism has been attributed to all onsets of IBDs, however, 
Mycobacterium paratuberculosis, M paramyxovirus, Listeria monocytogenes, and 
Helicobacter hepaticus have been implicated. (6) In IBS, the ratio of Firmicutes to 
Bacteroidetes has been shown to be altered in some cases (49) Recently, changes in the 
microbiome have even been associated with mood disorders and given rise to the idea of 
the microbiome influencing the gut-brain axis. (10) 
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 Commensal bacteria play a role in fermenting luminal contents that reach the colon. 
Some modify the bile salts that reach the colon (11). Others generate hydrogen, hydrogen 
sulfide, and methane. (12, 13) Many that digest the fiber and carbohydrate in the colon 
excrete short-chain fatty acids as a byproduct of their metabolism. 
1. D) Short-Chain Fatty Acids 
 Short-chain fatty acids (SCFAs) are fatty acids that consist of 2 to 6 carbons 
(acetate, propionate, butyrate, valerate, and caproate, respectively). In the colon they are 
the metabolic byproducts of anaerobic bacterial fermentation of carbohydrates and fiber 
that are not digested in the preceding regions of GI tract. The three most abundant in the 
colon are acetate, propionate, and butyrate. (14) Total concentrations of SCFAs vary 
depending on species, diet, as well as population and diversity of the microbiome, but their 
concentration is general thought to range between 70-140mM. Acetate is the most 
abundant, followed by butyrate and propionate, though the precise ratio is dependent on 
the same variables mentioned above. (15) 
 The concentrations of SCFAs are highest in the cecum and proximal colon, where 
most of the bacteria reside and where most undigested material is held in the colon. As 
material moves caudally, the SCFA concentration decreases due to their uptake and 
utilization as a nutrient source for colonocytes. Butyrate is considered to be the primary 
nutritive SCFAs for colonocytes. (16) It has been known for decades that SCFAs also play 
a role in the contractility of gastrointestinal smooth muscle, and several groups have 
previously studied the effect of SCFAs on motility of the distal ileum and colon. (17-22) 
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These studies have focused on such measurements as myoelectrical activity and transit 
time, as well as peptide release.  These findings will be discussed in detail in the discussion 
section. 
1. E) Gastrointestinal Motility Monitor (GIMM) 
 Measuring more detailed aspects of motility i.e. peristalsis and segmentation, has 
been relatively qualitative and difficult to assay in a precise manner. For instance, 
measuring luminal pressure and volume changes indicates nothing regarding different 
motility patterns. To attempt to solve this dilemma, video technology began to be utilized 
to record isolated tissue preparations for more detailed analysis. These analyses generate 
spatio-temporal maps of the video, which measure the distance from one lateral edge of the 
tissue to the other, and thus indicate either distension or occlusion of the intestinal lumen. 
(23, 54) In the decade since the inception of this method, it has been developed 
commercially and sold as a Gastrointestinal Motility Monitor (GIMM). (24)  
The primary use of GIMM by several groups has been to monitor propulsion of 
artificial fecal pellets in distal colon. Mawe has utilized this technique for studying the 
dysmotility of pellet propulsion in several animal models of inflammatory bowel diseases, 
particularly ulcerative colitis. (55,56) Others have used the technique to analyze peristalsis 
and segmentation by perfusing fluid intraluminally in the small and large intestine. (25-27) 
More recently, investigators working in Bornstein’s lab have tested the influence of 
nutrients on motility in the small intestine, and have attempted to show the role of the 
enteric nervous system in its coordination. (28,29,31) They have found that nutrient 
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induced motility is neurally mediated and can be blocked by tetrodotoxin, a sodium 
channel blocker; hyoscine/scopolamine, a muscarinic receptor antagonist; and 
hexamethonium, a nicotinic receptor antagonist. (28) Various methods of quantification 
have been employed, however, no consistent method has been agreed upon to define each 
motility pattern observed. The use of GIMM analysis has not yet been employed to 
investigate the role of SCFAs in motility. 
1. F) Short-chain fatty acid receptors and potential downstream signals. 
 There are two receptors known to detect SCFAs. Both are G-protein-coupled 
receptors (GPCRs) with seven-transmembrane domains. G-protein-coupled receptor 43 
(GPR43) and 41 (GPR41) have been shown as part of a family of GPCRs that detect free 
fatty acids. (35) The receptors have been renamed from GPR43 and GPR41 to free fatty 
acid receptor 2 (FFA2) and 3 (FFA3), respectively. Both of these receptors are expressed 
together in various cell types, such as adipose tissue, inflammatory cells, enteroendocrine 
L-cells in the GI tract, as well as pancreatic β cells. For this reason, investigation of the 
receptor effects via knockout animals has been difficult. (35) Recent pharmacological 
studies have shown that both of these receptors bind all SCFAs with varied potency. 
Propionate has the highest potency to FFA2, followed by acetate and butyrate, which are 
equipotent. Propionate and butyrate are equipotent at FFA3, whereas acetate is less potent 
at FFA3 compared to propionate and butyrate (33, 35) Both receptors are also able to 
couple with Gαi/o and thus inhibit adenylate cyclase, but only FFA2 is able to couple to 
Gαq and activate phospholipase C (PLC) and increase intracellular calcium levels. Based 
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on these known pathways, it is possible that SCFAs can affect several pathways in GI 
epithelial cells such as PYY release from L-cells as well as smooth muscle cells 
contraction and thus FFA2/3 are now under investigation as therapeutic targets.  (32, 35, 
36, 37) 
1. G) SCFAs and the microbiome in health and disease 
 Because the microbiome is sensitive to changes in diet and antibiotics, the potential 
exists for changes that can result in dysbiosis and facilitate the development of pathologies 
in the colon. Indeed, the role of the microbiome has come under the attention of clinical 
gastroenterology in recent years. (5,6,9, 38, 39) Studies have looked for correlations 
between changes in the microbiome, SCFA levels, and onset of certain diseases. 
Particularly, IBDs such as ulcerative colitis (UC) have been investigated clinically. (38, 
39) In UC patients, there was a significantly reduced microbial population compared to 
non-UC individuals. In regards to active versus inactive mucosal inflammation in UC 
patients, a shift in the microflora was also observed. Part of this rationale is focused on the 
bacterial production of SCFAs being diminished in UC or other IBDs. Because SCFAs are 
nutritive for colonocytes, a lack of SCFA production could result in a cellular stress 
response and cause the development of pathology. Even with adequate SCFA production, 
products from sulfur reducing bacteria (which are overgrown in UC) can block butyrate 
utilization by colonocytes. (38) 
 The microbiome has also been implicated in development of obesity. (38, 39) 
Again, many environmental factors play a role in the diversity of the microflora. Because 
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of this, it is more useful to assay the relative concentration of SCFA production as an 
indicator of certain bacterial populations. In one such study, two bacterial groups—
Firmicutes and Bacteroidetes—were assayed in lean and overweight and obese patients. 
(40) Additionally, relative SCFA levels were measured in the feces of patients. Compared 
to lean patients, overweight and obese patients showed a relative increase in Bacteroidetes 
and showed a relative increase in total SCFAs, with propionate being the most increased. 
(40) More recent studies have indicated that a normal level of SCFAs may be preventative 
toward obesity. (39) Through the activation of FFA2 in particular, the release of PYY or 
GLP-1 may be increased, which regulate digestive enzyme secretion and satiety among 
other factors. (41, 42) Activation of FFA2 on adipose tissue also inhibits lipolysis and 
increases adipogenesis while stimulating leptin secretion. (39) Due to these findings, as 
well as the potential role in IBDs, pharmacological studies have been designed to attempt 
to synthesize agonists for FFA2/3 as potential therapeutic targets. (35) 
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Rationale: 
 Given that dysbiosis contributes to several GI pathologies, including IBDs, IBS, 
and even diseases such as obesity, the effect of SCFAs is of clinical importance. However, 
the majority of current studies are focused on the cellular mediators and downstream 
effects that result from SCFA action on FFA2/3. Previous studies focusing on SCFAs in 
the colon have focused on smooth muscle characteristics and related this to motility, but 
lacked the technology to study motility in a whole tissue preparation in detail. With the 
development of the GIMM, this becomes possible. Owing to this experimental 
advancement, and the fact that dysmotility is also present in the above pathologies (38, 39), 
studying the connection between SCFAs and specific motility of the colon can help further 
characterize the role of SCFAs in gut function, and suggest implications for gut health and 
disease. 
Hypothesis: 
SCFA effects differ depending on location in the colon (proximal or distal), and 
also on chain length. 
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2. Materials and Methods 
 
2A. Reagents and Equipment 
 Acetate (C2H3O2Na, 82.03 g/mol, pKa = 4.76), Propionate (C3H5O2Na, 96.06 
g/mol, pKa = 4.87) and Butyrate (C4H7O2Na, 110.1 g/mol, pKa = 4.82), Sodium Chloride 
(NaCl, 58.44 g/mol), Potassium Chloride (KCl, 74.55 g/mol) and D-glucose (C6H12O6, 
180.2 g/mol)were purchased from Sigma-Aldrich, St. Louis, MO. Potassium Phosphate 
(KH2PO4, 136.09 g/mol) and Calcium Chloride (CaCl2, 147 g/mol) were purchased from 
Fischer Scientific, Pittsburgh, PA. Magnesium Sulfate (MgSO4, 246.48 g/mol) was 
purchased from JT Baker, Phillipsburg, NJ. Sodium Bicarbonate was purchased from 
Midwest Scientific, St. Louis, MO. All were kept at room temperature and were no less 
than 99% pure. The Gastrointestinal Motility Monitor (GIMM) was purchased from 
Catamount Research and Development, St. Albans, VT. The GIMM consists of several 
organ baths, which are placed on top of luminance plates to silhouette an intestinal 
segment, which is then recorded from above using a video camera connected to a 
computer running GIMM software. This allows for computer analysis of a modified 
Trendelenburg preparation as well as tracking of artificial fecal pellet velocity. (Figure 2)  
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Figure 2. Diagram Indicating Setup of the Gastrointestinal Motility Monitor.  
  A) The segment of intestine is excised and placed in an organ bath with 
circulating Krebs buffer (pH 7.4, 37oC). In the proximal colon the orad and caudad ends 
are cannulated with glass tubes, tied with suture, and attached to the walls of the organ 
bath by molding clay. The organ bath sits on a tray that emits light from below and 
causes the tissue to be silhouetted in view of the video camera situated above the 
preparation. This camera is attached to a computer that records and analyzes the motility 
patterns of the tissue over a specified timeframe.  In order to distend the proximal colon a 
caudad clamp is closed and fluid is added via an orad syringe. These together are used to 
control the volume of fluid in the lumen. B) In the distal colon the setup is identical, but 
the cannulas are removed and a fine catheter (PE 10) is inserted into the anal end and 
advanced about half way into the colon towards the pellet.  Experimental fluids are 
infused through this catheter at a rate of 0.1 ml/min via a syringe and syringe pump. 
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Figure 2. Diagram Indicating Setup of the Gastrointestinal Motility Monitor. 
 
 
 
A 
B 
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2B. Animals 
 Hartley guinea pigs of either sex and 150-200g weight were purchased from 
Charles River Laboratories International and euthanized by asphyxiation with carbon 
dioxide as approved by the Institutional Animal Care and Use Committee of Virginia 
Commonwealth University. The animals were housed in the animal facility administered 
by the Division of Animal Resources, Virginia Commonwealth University.  All 
procedures were conducted in accordance with the Institutional Animal Care and Use 
Committee of the Virginia Commonwealth University. 
 
2C. Preparation of Tissues and Equipment 
 Following euthanasia, the abdominal cavity was dissected and the proximal and 
distal colon were removed and place in warmed Krebs buffer (pH 7.4) which contained 
(in mM): 118 NaCl, 4.75 KCl, 1.19 KH2PO4, 1.2 MgSO4, 2.54 CaCl2, 25 NaHCO3, 11 
Glucose. Krebs buffer was bubbled with 95% oxygen and 5% carbon dioxide. 
Proximal colon was cut to approximately 8 cm, flushed of feces and cannulated 
using custom-built glass tubes on the orad and caudad ends. Following this, the proximal 
colon and cannulas were placed in one of the GIMM organ baths. The baths contained 
Krebs buffer and were continuously perfused with fresh oxygenated Krebs buffer held at 
37oC. To achieve 37oC in the organ bath, the perfused Krebs buffer was sent through a 
series of heating coils circulating water from a perfusion pump held at 52oC. Krebs buffer 
of the same oxygenation and temperature was also injected into the lumen of the 
proximal colon through the orad cannula and left to equilibrate for approximately 15 
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minutes. During this period the caudad cannula was left open to allow the tissue to clear 
itself of contents as a result of native propulsive motility. 
Distal colon was cut into 3-4 segments of approximately 5 cm, placed into the 
GIMM organ baths, pinned at the orad and caudad ends at their in situ length, and  
 allowed to expel natural pellets for approximately 10 minutes, after which point any 
remaining pellets were flushed out with Krebs buffer. Following expulsion of pellets, 
distal colon was left to equilibrate for 5-10 minutes.  
 The GIMM cameras were then calibrated in the dark to record the colon 
segments. Calibration involved adjustments of distance (mm) as well as camera focus and 
aperture to properly visualize the segments against the background luminance plates. 
Proper adjustment yielded a silhouette of the proximal colon such that it was the only 
dark area on the computer screen, absent of any marks or bubbles that were present in the 
organ bath. Proper adjustment for recording of distal colon yielded a “washed out” visual 
display such that the tissue was hardly visible. This allowed for proper tracking of the 
dark artificial pellet that would later be used in the experiment. 
 
2D. Proximal Colon Response to Intraluminal Distension 
 Following equilibration, the caudad cannula was clamped shut to prevent fluid 
from being expelled and the segment was injected with Krebs buffer via the orad cannula. 
Because the orad syringe and caudad clamp resulted in a closed system, all excess 
injected Krebs buffer volume was displaced into the lumen of the proximal colon, 
resulting in distension of the tissue. The volume was increased in 0.5ml increments from 
0.0-2.0ml every 5 minutes and recorded continuously throughout the 25-minute 
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experiment. Video was later analyzed using GIMM software to determine the minimum-
effective distension to visualize motility of the proximal colon. Throughout following 
experiments with treatment of SCFAs, the initial control was used to determine the 
minimum effective distension for each segment used. It was found that in all segments of 
approximately 8cm, distension of 0.5-1.0ml was sufficient to visualize motility. (Figure 
3) 
 
2E. Proximal Colon Response to Experimental Treatments 
 In all treatment experiment trials, the segments were distended and recorded for 
10-minute periods. During analysis, the last 5 minutes of each video were used. Each 10-
minute trial was followed by removing the clamp, allowing the proximal colon to empty 
and then pushing Krebs buffer through the orad cannula and tissue to clear the system of 
the treatment solution. The segment was then left to rest for 10-15 minutes until the next 
trial. Each experimental treatment was preceded by a control distension of Krebs buffer 
in order to establish a baseline of motility patterns for the proximal segment. Following 
this, several experimental conditions were tested: 
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Figure 3. Distension-Response Map of the Guinea Pig Proximal Colon 
 The proximal colon was recorded continuously for 1500 seconds (25 minutes) 
during which time distension volumes are increased from 0.0 – 2.0 ml in 0.5 ml 
increments every 300 seconds (5 minutes). The incremental darkening of the map 
indicates the increase in overall diameter of the segment as distension occurs. Each white 
band (arrow) that slopes from the right (orad) side of the map to the left (caudad) side of 
the map indicates a decrease in diameter  (contraction) of the segment which propagates 
in the caudad direction. These were termed “full proagations” This is most clear at 1.0 ml 
(middle section) and is thus considered the minimum effective distension volume of the 
segment. The small key next to the spatiotemporal map indicates the diameter of the 
tissue based on shading. The key is also representative of 1/10th of the Y-axis (time) and 
the X-axis (length of segment within view of the camera). 
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Figure 3. Distension-Response Map of the Guinea Pig Proximal Colon 
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2E.1) Treatment with single SCFAs (dose-response) 
 Acetate, propionate, or butyrate were added to Krebs buffer to make 10, 30, and 
100mM solutions which were then used to distend the proximal colon for 10 minutes of 
video. A Krebs washout and rest period followed each dose before  
adding the next dose. Because of the time used for the experiments (1.5-2 hours), doses 
were shuffled at random in order to determine motility changes were dose dependent and 
not time dependent. Time controls (i.e. repetitive trials with Krebs buffer only) were also 
performed for this experimental scheme to verify that there was no time dependence on 
motility. 
 
2E.2) Perfusion with 100mM NaCl 
 Because Na+ is included with all of the SCFAs, the possibility exists that any 
observed change could be the result of an equimolar amount of sodium being added to 
the Krebs buffer (10, 30, 100mM respectively). For this reason, several control 
experiments were performed using a 10-minute distension using Krebs buffer with 
100mM NaCl added following a baseline trial of standard Krebs buffer. These control 
experiments showed no difference for an additional 100mM NaCl versus standard Krebs 
buffer. 
 
2E.3) pH variations due to SCFAs and buffer shift 
 Given that the pKa values of the SCFAs occur between 4.7 and 4.9, it is not 
expected that these would have any effect on the pH of the buffer in the concentrations 
used. However, the pH values of SCFA solutions as well as perfused Krebs buffer 
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without SCFAs were tested at random. No difference was observed between the pH of 
Krebs buffer alone or with added SCFAs at any concentration. However, throughout the 
experiment the pH of the Krebs buffer would shift slightly from 7.4 to 7.6 
 
2E.4) Mixtures of SCFAs 
 Two mixtures of all three SCFAs were used following a 10-minute control 
recording with Krebs buffer alone. Both mixtures were used in a single experiment, but 
their order was randomized in order to discern if there was a marked difference from each 
other. The two mixtures consisted of an equivalent dosage ratio (10mM Acetate:10mM 
Propionate:10mM Butyrate) and physiological ratio which mimicked that reported to 
often occur in colonic samples (15mM Acetate:10mM Butyrate:5mM Propionate). These 
dosages were chosen based on the initial dose-response experiments with each individual 
SCFA, and were formulated to carry equivalent total SCFAs between the two mixtures 
(30mM vs 30mM). 
 
2F) Distal Colon Propulsion of Fecal Pellets 
 For these experiments, the chamber, transillumination, videorecording technique, 
Krebs’ buffer solutions, and temperature/oxygenation/pH monitoring were identical to 
those described for fluid-induced motility experiments described above. Following 
equilibration, an artificial clay pellet designed to mimic native pellets in size (on average 
12 x 5 mm) and shape was inserted into the orad end of the distal colon and its movement 
throughout was recorded using the GIMM video camera. This was repeated at least 3 
times in order to establish a consistent baseline velocity. Trials were recorded for as long 
   
 24 
as it took to propel the pellet, but would be ended after 5 minutes if propulsion had not 
completely expelled the pellet.  At this point the pellet would be forced out using 
injection of a small amount of Krebs buffer to flush the lumen. 
 Upon completion of the control pellet propulsion videorecoding, a 10ml syringe 
containing a Krebs buffer solution with an individual SCFA at 30mM would be placed in 
a syringe pump and set to push 0.1ml/min through a flexible plastic tube (PE 10) attached 
to the syringe and inserted in the caudad end roughly to the midpoint of the distal colon 
segment. This allowed for solution to be perfused into the lumen ahead (i.e. just caudad) 
of the artificial fecal pellet which was inserted into the orad end. The same period of time 
for videorecording of pellet movement was used as in the control trials. In control studies, 
pellet movement was videorecorded in the same segment without perfusion of Krebs 
buffer and during perfusion of Krebs buffer alone in the same system (PE 10 tubing; 
perfusion at a rate of 0.1ml/min).  There was no difference in pellet propulsion in the 
absence and presence of Krebs buffer perfusion indicating that this rate did not affect 
motility via a mechanical effect. The velocities were 1.35 ±	 0.1 mm/s and 1.36 ±	 0.2 
mm/s respectively. 
 
2G) Video Recording and Quantification of the Proximal Colon 
  Using the 10-minute (600 second) videos, the GIMM software was used to 
analyze the motility of the proximal colon in response to treatment at the minimum 
effective distension during the last 5 minutes (300 – 600 seconds). The software does this 
by detecting the lateral edges of the tissue segment and measuring the distance between 
them. Increased distance between edges (i.e. relaxation) is represented as darkening and 
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decreased distance between edges (i.e. contraction) as lightening on a 2-dimensional 
spatiotemporal map in which the X-axis represents distance from orad to caudad and the 
Y-axis represents time from approximately 300 – 600 seconds of the video recording. 
(Figure 4) 
 Two main motility patterns were differentiated using the spatiotemporal maps. 
The first is a propulsive, propagating wave of contraction that moved caudad throughout 
the segment. In quantifying this, propulsive waves were separated into short-propagations 
and full-propagations. This was determined based on the propagation length in the 
segment: if greater than half the distance, it was called a full-propagation; if shorter than 
half the distance, it was called a short-propagation. Full-propagations therefore began in 
the orad half of the segment. Typically, short propagations would begin in the caudad 
half of a segment. However, any propagation that began in the orad half and propagated 
less than half the distance of the segment would be quantified as a short-propagation. 
These values were also combined to determine the total propagations within a 300 second 
period. (Figure 5) 
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Figure 4.  Example of Spatiotemporal Map of Proximal Colon 
A typical example of a spatiotemporal map showing approximately 300 seconds 
(5 minutes) of motility in the proximal colon. Propagating contractions are seen as light 
bands which angle from the right (orad) side to the left (caudad) side. The dark black 
bulb at the end of the propagation is an artifact distension that results from luminal fluid 
being pushed against the resistance of the clamp on the caudad cannula. Non-propagating 
contractions of various lengths are observed as short white bands interspersed between 
the propagating contractions.
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Figure 4. Example of Spatiotemporal Map (Caudad – Orad) 
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Figure 5. Example of Solitary Propagating Contractions in Proximal Colon 
Pictured are three propagating contractions seen against an otherwise quiescent 
section of proximal colon. The various horizontal dark bands within each propagation are 
indications of artifact that is the result of the clamp on the caudad cannula, which inhibits 
the expulsion of luminal fluid. This results in an apparent fractioned propagation on the 
spatiotemporal map, but does not introduce a confounding distension effect to the 
motility of the segment. This is indicated by the quiescence present following the 
propagating contraction.
   
 29 
Figure 5. Example Spatiotemporal Map of Propagating Contraction  
(Caudad – Orad) 
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 The second main motility pattern observed was a non-propagating, mixing 
contraction. This contraction pattern rarely completely occluded the lumen and would 
often be seen on the mesenteric side of the proximal colon only. Typically this 
contraction was 1-3mm in length but could be as large as 8mm. However, given that it is 
difficult to be this precise using the spatiotemporal maps, a maximum cutoff of 
approximately 10mm (or 1/5th of the segment length) was used. In some cases, small 
ripple-like patterns would be observed and move between 5 and 15mm and appear as a 
small propagation on the spatiotemporal map. However, because these ripple-like 
patterns did not result in occlusion of the lumen, were observed infrequently, and only 
occurred on the mesenteric side of the proximal colon, they were counted as a single 
contraction in the total pool of non-propagating contractions. (Figure 6) 
 Despite the above methods for quantification, some aspects of motility in the 
proximal colon were not able to be numerically counted due to the level of variance 
observed from one segment to the next. The primary example of this was seen during 
equilibration and throughout most of the control trials using Krebs buffer at the beginning 
of every experiment. This motility pattern is best described as a “twitch” that involved 
contraction of nearly the entire segment in unison. This is considered qualitatively in 
addition to the propagating and non-propagating contractions to define “overall motility” 
of a segment. (Figure 7) 
2H) Velocity Analysis of Artificial Fecal Pellets in the Distal Colon 
 Velocity analysis was performed using the pellet tracking method in the GIMM 
software, in which the pellet is darkened compared to the rest of the video and tracked 
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from the orad to caudad end. Velocity is calculated and displayed in mm/sec. In using 
velocity values, and minimum travel distance of 20mm was determined, as it was not 
common to see a pellet propel continuously farther than this distance. The velocities for 
each condition were averaged each day, yielding two mean values from each experiment 
indicating a control velocity and a treatment velocity. (Figure 8) 
B8) Statistical Analysis 
 Prism GraphPad statistical software was used to analyze the data. Two-tailed t-
tests and One-Way ANOVA were the two tests used depending on the number of 
conditions per experiment, with a Dunnett’s multiple comparisons post-hoc test being 
performed on significant ANOVAs. Graphical representations of the results represent the 
Mean±SEM with significance denoted with * and representing p ≤ 0.05
   
 32 
 
 
 
 
Figure 6. Example of Non-Propagating Contractions in Proximal Colon 
 Non-propagating contractions are pictured as isolated white bands between 1 - 
10mm. These contractions can be singular or occur simultaneously with other 
contractions along the length of colon. In the figure, both are seen. The majority of the 
non-propagations are coordinated with others, which results in the checkerboard like 
pattern displayed in the map
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Figure 6. Example Spatiotemporal Map of Non-Propagating Contraction  
mm
7.9
4.3
4.3 mm
30.1 s     
   
 34 
 
 
 
 
Figure 7. Example Spatiotemporal Map Displaying “Twitch” Motility 
 Many control trials displayed a spatiotemporal map that was similar to this figure. 
This is a profound example of the propagating and non-propagating contractions, which 
are buried in rapidly occurring bands that resemble a twitch of the entire segment. In 
most cases, propagations were still clearly distinguishable; however, non-propagations 
were more difficult to accurately quantify. For this reason, an indication of changes in 
“overall motility” from control versus any experimental solution was included in the 
results. 
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Figure 7. Example Spatiotemporal Map Showing “Twitch”  Motility 
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Figure 8. Example Spatiotemporal Map Showing Pellet Movement in Distal Colon 
 Shown is a spatiotemporal map illustrating the distension of the distal colon 
induced by a fecal pellet as it is propelled from the orad end more caudally. Using the Y-
axis of time (seconds) and X-axis of distance (millimeters), it is possible to calculate the 
velocity of pellet movement (mm/s). The GIMM software contains pellet-tracking 
software that allows for velocity calculations without the generation of a spatiotemporal 
map. This figure is included only to demonstrate the differences between methods in the 
proximal versus distal colon, and how this is recorded by the computer. 
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Figure 8. Example Spatiotemporal Map Showing Pellet Movement in Distal Colon 
(Orad – Caudad) 
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3. Results 
 
3A) Response of Proximal and Distal Colon to Butyrate 
 In the proximal colon, four series of quantification were taken for each dose of 
butyrate that was perfused into the lumen. Full propagations and half propagations were 
measured separately and then combined for determine total propagations. Non-
propagating contractions were counted and recorded.  
 Full propagations were the clearest to distinguish on the spatiotemporal map. The 
control baseline frequency of full propagations in response to distension with Krebs 
buffer in seven proximal colons from seven guinea pigs was 2.0 ± 0.6 per 5-minute 
period.  10mM butyrate solution increased the frequency of full propagations by 178% of 
control to a value of 5.6 ± 0.8 per 5-minute period. 30mM butyrate solution also 
increased the frequency of full propagations by 207% of control to 6.1 ± 0.5 per 5-minute 
period.  100mM butyrate solution increased the frequency of full propagations by 121% 
of control to a value of 4.4±0.6 per 5-minute period. (Figure 9A) 
 Short propagations had a control baseline frequency of 3.3 ± 1.2 per 5-minute 
period. 10mM butyrate increased the frequency of short propagations by 13% of control 
to 3.7 ± 1.7 per 5-minute period, but 30mM decreased the frequency of short 
propagations by 65% from control to 1.1 ± 0.5 per 5-minute period.  100mM butyrate 
further decreased the frequency of short propagations by 87% from control to 0.4 ± 0.4 
per 5-minute period. (Figure 9B) 
 Total propagations were summations of both the full and short propagations, 
which showed a baseline frequency of 5.3 ± 1.4 per 5-minute period. 10mM butyrate 
increased the frequency of total propagations by 75% of control to 9.3 ± 2 per 5-minute 
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period, while 30mM butyrate increased the frequency of total propagations by 35% of 
control to 7.1 ± 0.7 per 5-minute period. 100mM butyrate decreased the frequency of 
total propagations by 8% from control to 4.9 ± 0.8 per 5-minute period. (Figure 9C) 
 Non-propagating contractions had a control baseline frequency of 68.6 ± 8.9 per 
5-minute period. 10mM butyrate increased the frequency of non-propagations by 46% of 
control to 100.6 ± 26.0 per 5-minute period. 30mM butyrate increased the frequency of 
non-propagations by 26% of control to 86.7 ± 11.0 per 5-minute period. 100mM butyrate 
decreased the frequency of non-propagations by 58% to 29.0 ± 9.0 per 5-minute period.  
(Figure 10) 
	   Overall	  motility	  of	  all	  seven	  proximal	  colons	  increased	  following	  perfusion	  of	  butyrate	  at	  10mM	  and	  remained	  increased	  at	  increasing	  concentrations.	  Propagating	  motility	  was	  more	  prominent	  than	  non-­‐propagations	  following	  perfusion	  of	  butyrate	  at	  100mM.	  Propagating	  contractions	  also	  increased	  in	  duration	  of	  contraction	  (occlusion)	  compared	  to	  control,	  as	  indicated	  by	  the	  thickness	  of	  the	  bands	  on	  the	  spatiotemporal	  maps.	  (Figure	  11)	  	   In	  the	  distal	  colon,	  artificial	  fecal	  pellets	  were	  inserted	  into	  the	  orad	  end	  and	  the	  velocity	  was	  tracked	  using	  GIMM	  software.	  The	  baseline	  velocity	  of	  three	  segments	  from	  three	  guinea	  pigs	  was	  1.22	  ±	  0.1	  mm/s.	  Following	  treatment	  of	  30mM	  butyrate	  via	  intraluminal	  perfusion	  at	  0.1ml/min	  caudad	  to	  the	  pellet,	  the	  velocity	  increased	  30%	  to	  1.6	  ±	  0.1	  mm/s.	  	  (figure	  12)	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Figure	  9.	  Effect	  of	  Butyrate	  on	  Propagating	  Contractions	  in	  Proximal	  Colon	  
	  
	   Butyrate	  in	  solution	  in	  Krebs	  buffer	  (0.5	  to	  1.0	  ml)	  was	  perfused	  into	  the	  lumen	  of	  proximal	  colon	  closed	  on	  the	  caudad	  end	  and	  was	  used	  to	  cause	  minimal	  distension.	  (A)	  At	  all	  doses,	  butyrate	  increased	  full-­‐length	  propagations	  with	  the	  greatest	  increase	  at	  30mM.	  (B)	  With	  increasing	  concentration,	  short	  propagations	  were	  diminished	  in	  favor	  of	  full-­‐length	  propagations.	  (C)	  The	  opposing	  effects	  of	  butyrate	  on	  full-­‐length	  vs.	  short	  propagations	  resulted	  in	  a	  non-­‐significant	  change	  in	  total	  contractions.	  	  Data	  represents	  number	  of	  propagated	  contractions	  per	  5	  min	  period	  (n=7,	  Mean	  ±	  SEM,	  p	  <	  0.05)
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Figure	  9.	  Effect	  of	  Butyrate	  on	  Propagating	  Contractions	  in	  Proximal	  Colon	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Figure	  10.	  Effect	  of	  Butyrate	  on	  Non-­‐Propagating	  Contractions	  in	  Proximal	  
Colon	  	  	   Following	  perfusion	  and	  distension	  using	  a	  solution	  of	  butyrate	  in	  Krebs	  buffer,	  non-­‐propagations	  were	  quantified	  in	  the	  proximal	  colon.	  At	  10mM,	  butyrate	  increased	  non-­‐propagating	  contractions.	  As	  the	  concentration	  increased,	  non-­‐propagations	  decreased.	  At	  100mM,	  these	  non-­‐propagations	  were	  significantly	  decreased.	  Data	  represents	  number	  of	  non-­‐propagated	  contractions	  per	  5	  min	  period	  	  (n=7,	  Mean	  ±	  SEM,	  p	  <	  0.05)
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Figure	  10.	  Effect	  of	  Butyrate	  on	  Non-­‐Propagating	  Contractions	  in	  Proximal	  
Colon	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Figure	  11.	  Overall	  Motility	  of	  Proximal	  Colon	  Following	  Butyrate	  Treatment	  	  	   Compared	  to	  control,	  an	  overall	  increase	  in	  motility	  in	  the	  proximal	  colon	  was	  observed	  following	  luminal	  perfusion	  of	  butyrate	  solution.	  As	  the	  concentration	  of	  butyrate	  increased,	  non-­‐propagations	  were	  decreased	  in	  favor	  of	  propagating	  contractions.	  The	  propagated	  contractions	  were	  of	  increased	  duration	  compared	  to	  control,	  as	  indicated	  by	  band	  thickness.
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Figure	  11.	  Overall	  Motility	  of	  Proximal	  Colon	  Following	  Butyrate	  Treatment	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Figure	  12.	  Mean	  Pellet	  Velocity	  Following	  Caudad	  Perfusion	  of	  30mM	  Butyrate	  	  	   Following	  perfusion	  of	  30mM	  butyrate	  via	  a	  flexible	  catheter	  (PE	  10	  tubing)	  inserted	  in	  the	  caudad	  end	  of	  distal	  colon,	  pellet	  velocity	  was	  increased	  compared	  to	  control	  velocity.	  Control	  velocities	  were	  1.2	  ±	  0.1	  mm/s	  and	  increased	  to	  1.6	  	  ±	  0.1	  mm/s	  following	  30mM	  butyrate	  intraluminal	  perfusion.	  (n=3,	  Mean	  ±	  SEM,	  p	  <	  0.05)	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Figure	  12.	  	  Mean	  Pellet	  Velocity	  of	  Artificial	  Fecal	  Pellet	  Following	  30mM	  
Caudad	  Perfusion	  in	  Distal	  Colon	  
	  
	  
	  
	  
   
 48 
	  
3B)	  Response	  of	  Proximal	  and	  Distal	  Colon	  to	  Propionate	  
	  	   Full	  propagations	  in	  the	  proximal	  colons	  of	  nine	  guinea	  pigs	  had	  a	  baseline	  frequency	  of	  full	  propagations	  of	  3.0	  ±	  1.0	  per	  5-­‐minute	  period.	  These	  propagations	  were	  completely	  abolished	  at	  10mM	  propionate.	  At	  30mM	  propionate,	  the	  frequency	  of	  full	  propagations	  were	  decreased	  by	  96%	  from	  control	  to	  a	  value	  of	  0.2	  ±	  0.2	  per	  5-­‐minute	  period.	  100mM	  propionate	  decreased	  the	  frequency	  of	  full	  propagations	  by	  54%	  from	  control	  to	  a	  value	  of	  1.4	  ±	  0.4	  per	  5-­‐minute	  period.	  
(Figure	  13A)	  	   Short	  propagations	  were	  similarly	  decreased	  from	  a	  baseline	  frequency	  of	  short	  propagations	  of	  2.0	  ±	  0.4	  per	  5-­‐minute	  period.	  At	  10mM	  concentration,	  short	  propagations	  were	  completely	  abolished.	  30mM	  propionate	  decreased	  the	  frequency	  of	  short	  propagations	  by	  89%	  from	  control	  to	  a	  value	  of	  0.2	  ±	  02	  per	  5-­‐minute	  period.	  At	  100mM,	  propionate	  decreased	  the	  frequency	  of	  short	  propagations	  by	  33%	  from	  control	  to	  a	  value	  of	  1.3	  ±	  1.0	  per	  5-­‐minute	  period.	  	  
(Figure	  13B)	  	  	   Total	  propagations	  were	  summations	  of	  both	  the	  full	  and	  short	  propagations,	  which	  showed	  a	  baseline	  control	  frequency	  of	  4.8	  ±	  1.2	  per	  5-­‐minute	  period.	  10mM	  propionate	  completely	  abolished	  propagations,	  while	  30mM	  decreased	  the	  frequency	  of	  total	  propagations	  by	  90%	  from	  control	  to	  a	  0.4	  ±	  0.3	  per	  5-­‐minute	  period.	  100mM	  propionate	  decreased	  the	  frequency	  of	  total	  propagations	  by	  42%	  from	  control	  to	  2.8	  ±	  1.3	  per	  5-­‐minute	  period.	  (Figure	  13C)	  	   Non-­‐propagating	  contractions	  had	  a	  baseline	  frequency	  of	  76	  ±	  24	  per	  5-­‐minute	  period.	  At	  10mM,	  propionate	  decreased	  the	  frequency	  of	  non-­‐propagations	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by	  68%	  from	  control	  to	  24	  ±	  12.	  per	  5-­‐minute	  period.	  30mM	  propionate	  increased	  the	  frequency	  of	  non-­‐propagations	  by	  52%	  of	  control	  to	  115	  ±	  40	  per	  5-­‐minute	  period.	  100mM	  propionate	  further	  increased	  the	  frequency	  of	  non-­‐propagations	  by	  64%	  of	  control	  to	  124	  	  ±	  45	  per	  5-­‐minute	  period.	  (Figure	  14)	  Overall	  motility	  in	  all	  nine	  proximal	  colons	  was	  decreased	  following	  perfusion	  of	  propionate	  at	  10mM,	  with	  a	  return	  of	  non-­‐propagating	  motility	  at	  30mM	  and	  100mM.	  Propagating	  motility	  increased	  with	  propionate	  concentration,	  but	  remained	  slightly	  diminished	  from	  control.	  (Figure	  15)	  	   The	  propulsion	  of	  artificial	  pellets	  through	  the	  distal	  colon	  was	  recorded	  from	  four	  segments	  from	  four	  guinea	  pigs	  and	  the	  velocity	  was	  calculated.	  The	  control	  baseline	  velocity	  was	  1.7	  ±	  0.2	  mm/s.	  Following	  treatment	  with	  30mM	  propionate	  via	  intraluminal	  perfusion	  at	  0.1	  ml/min	  caudad	  to	  the	  pellet,	  the	  velocity	  decreased	  by	  75%	  to	  0.4	  ±	  0.2	  mm/s.	  	  	  (Figure	  16)	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Figure	  13.	  Effect	  of	  Propionate	  on	  Propagating	  Contractions	  in	  Proximal	  Colon	  
	   Propionate	  in	  solution	  in	  Krebs	  buffer	  (0.5	  to	  1.0	  ml)	  was	  perfused	  into	  the	  lumen	  of	  proximal	  colon	  closed	  on	  the	  caudad	  end	  and	  was	  used	  to	  cause	  minimal	  distension.	  (A)	  At	  all	  doses,	  propionate	  decreased	  full-­‐length	  propagations	  versus	  control,	  with	  the	  greatest	  decrease	  at	  10mM.	  (B)	  Short	  propagations	  were	  diminished	  at	  lower	  concentrations,	  and	  abolished	  at	  10mM.	  (C)	  The	  inhibitiory	  effect	  of	  propionate	  on	  propagations	  showed	  an	  overall	  decrease	  in	  total	  propagations.	  Data	  represents	  number	  of	  propagations	  per	  5	  min	  period.	  (n=9,	  Mean	  ±	  SEM,	  p	  <	  0.05)
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Figure	  13.	  Effect	  of	  Propionate	  on	  Propagating	  Contractions	  in	  Proximal	  Colon	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Figure	  14.	  Effect	  of	  Propionate	  on	  Non-­‐Propagating	  Contractions	  in	  Proximal	  
Colon	  
	   Following	  perfusion	  and	  distension	  using	  a	  solution	  of	  propionate	  in	  Krebs	  buffer,	  non-­‐propagations	  were	  quantified	  in	  the	  proximal	  colon.	  At	  10mM,	  propionate	  decreased	  non-­‐propagating	  contractions.	  As	  the	  concentration	  increased,	  non-­‐propagations	  increased.	  This	  increase	  in	  non-­‐propagations	  was	  generally	  opposed	  to	  the	  effect	  on	  propagations	  above	  30mM.	  Data	  represents	  number	  of	  non-­‐propagated	  contractions	  per	  5	  min	  period.	  (n=9,	  Mean	  ±	  SEM)
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Figure	  14.	  Effect	  of	  Propionate	  on	  Non-­‐Propagating	  Contractions	  in	  Proximal	  
Colon	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Figure	  15.	  Overall	  Motility	  of	  Proximal	  Colon	  Following	  Propionate	  Treatment	  
	   Compared	  to	  control,	  an	  overall	  decrease	  in	  motility	  in	  the	  proximal	  colon	  was	  observed	  following	  luminal	  perfusion	  of	  propionate	  solution.	  As	  the	  concentration	  of	  propionate	  increased,	  motility	  increased	  but	  remained	  low	  compared	  to	  control.	  	  Non-­‐propagations	  were	  more	  frequent	  at	  higher	  concentrations	  of	  propionate	  compared	  to	  propagating	  contractions.
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Figure	  15.	  Overall	  Motility	  of	  Proximal	  Colon	  Following	  Propionate	  Treatment	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Figure	  16.	  Mean	  Pellet	  Velocity	  Following	  Caudad	  Perfusion	  of	  30mM	  
Propionate	  
	   Following	  perfusion	  of	  30mM	  propionate	  via	  a	  flexible	  catheter	  (PE	  10	  tubing)	  inserted	  in	  the	  caudad	  end	  of	  distal	  colon,	  pellet	  velocity	  was	  decreased	  compared	  to	  control	  velocity.	  Control	  velocities	  were	  1.7	  ±	  0.2	  mm/s	  and	  decreased	  to	  0.4	  ±	  0.2	  mm/s	  following	  30mM	  butyrate	  intraluminal	  perfusion.	  (n=4,	  Mean	  ±	  SEM,	  p	  <	  0.05)
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Figure	  16.	  Mean	  Pellet	  Velocity	  Following	  Caudad	  Perfusion	  of	  30mM	  
Propionate	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C3)	  Response	  of	  Proximal	  and	  Distal	  Colon	  to	  Acetate	  	   Full	  propagations	  had	  a	  baseline	  frequency	  of	  3.3	  ±	  0.7	  per	  5-­‐minute	  period.	  At	  10mM,	  acetate	  decreased	  the	  frequency	  of	  full	  propagations	  40%	  from	  control	  to	  2.0	  ±	  0.58	  per	  5-­‐minute	  period.	  30mM	  acetate	  decreased	  the	  frequency	  of	  full	  propagations	  30%	  from	  control	  to	  2.3	  ±	  0.3	  per	  5-­‐minute	  period,	  while	  100mM	  acetate	  increased	  the	  frequency	  of	  full	  propagations	  10%	  of	  control	  to	  3.7	  ±	  0.9	  per	  5-­‐minute	  period.	  (Figure	  17A)	  
Short	  propagations	  showed	  an	  overall	  decrease	  from	  a	  baseline	  frequency	  of	  7.0	  ±	  2.1	  per	  5-­‐minute	  period.	  At	  10mM,	  acetate	  decreased	  the	  frequency	  of	  short	  propagations	  24%	  from	  control	  to	  5.3	  ±	  1.5	  per	  5-­‐minute	  period.	  30mM	  acetate	  further	  decreased	  the	  frequency	  of	  short	  propagations	  57%	  from	  control	  to	  3.0	  ±	  1.2	  per	  5-­‐minute	  period,	  and	  100mM	  acetate	  decreased	  the	  frequency	  of	  short	  propagations	  81%	  from	  control	  to	  1.3	  ±	  0.9	  per	  5-­‐minute	  period.	  (Figure	  17B)	  
	   Total	  propagations	  were	  summations	  for	  full	  and	  short	  propagations	  with	  a	  baseline	  frequency	  of	  10.3	  ±	  1.4	  per	  5-­‐minute	  period.	  10mM	  acetate	  decreased	  the	  frequency	  of	  total	  propagations	  29%	  from	  control	  to	  7.3	  ±	  1.3	  per	  5-­‐minute	  period.	  30mM	  acetate	  further	  decreased	  the	  frequency	  of	  total	  propagations	  45%	  from	  control	  to	  5.7	  ±	  1.4	  per	  5-­‐minute	  period,	  and	  100mM	  decreased	  the	  frequency	  of	  total	  propagations	  51%	  from	  control	  to	  5.0	  ±	  1.7	  per	  5-­‐minute	  period.	  (Figure	  17C)	  	  
	   Non-­‐propagations	  had	  a	  baseline	  frequency	  of	  99.7	  ±	  23	  per	  5-­‐minute	  period.	  10mM	  decreased	  the	  frequency	  of	  non-­‐propagations	  49%	  from	  control	  to	  50.7	  ±	  15	  per	  5-­‐minute	  period.	  30mM	  acetate	  decreased	  the	  frequency	  of	  non-­‐propagations	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40%	  from	  control	  to	  59.3	  ±	  12	  per	  5-­‐minute	  period.	  100mM	  acetate	  decreased	  the	  frequency	  of	  non-­‐propagations	  56%	  from	  control	  to	  43.7	  ±	  6.4	  per	  5-­‐minute	  period.	  
(Figure	  18)	  
	   Overall	  motility	  was	  decreased	  in	  all	  three	  proximal	  colons	  following	  perfusion	  of	  acetate	  and	  continued	  to	  decrease	  as	  concentration	  was	  increased.	  Both	  propagations	  and	  non-­‐propagations	  showed	  an	  overall	  decrease	  compared	  to	  control.	  (Figure	  19)	  
	   The	  propulsion	  of	  artificial	  pellets	  through	  the	  distal	  colon	  was	  recorded	  from	  two	  segments	  from	  two	  guinea	  pigs	  and	  the	  velocity	  was	  calculated.	  The	  control	  baseline	  velocity	  was	  1.8	  ±	  0.1mm/s.	  Following	  treatment	  of	  30mM	  acetate	  via	  intraluminal	  perfusion	  at	  0.1ml/min	  caudad	  to	  the	  pellet,	  the	  velocity	  decreased	  47%	  to	  0.95	  ±	  0.3	  mm/s.	  	  (Figure	  20)	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Figure	  17.	  Effect	  of	  Acetate	  on	  Propagating	  Contractions	  in	  Proximal	  Colon	  
	   Acetate	  in	  solution	  in	  Krebs	  buffer	  (0.5	  to	  1.0	  ml)	  was	  perfused	  into	  the	  lumen	  of	  proximal	  colon	  closed	  on	  the	  caudad	  end	  and	  was	  used	  to	  cause	  minimal	  distension.	  (A)	  At	  all	  doses,	  acetate	  had	  no	  significant	  effect	  on	  full-­‐length	  propagations	  versus	  control.	  As	  dose	  increased,	  full	  propagations	  tended	  to	  increase	  back	  to	  control	  values.	  (B)	  Short	  propagations	  were	  diminished	  at	  higher	  concentrations.	  (C)	  The	  overall	  inhibitiory	  trend	  of	  acetate	  on	  propagations	  showed	  a	  decrease	  in	  total	  propagations.	  Data	  represent	  number	  of	  propagations	  per	  5	  min	  period.	  (n=3,	  Mean	  ±	  SEM)
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Figure	  17.	  Effect	  of	  Acetate	  on	  Propagating	  Contractions	  in	  Proximal	  Colon	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Figure	  18.	  Effect	  of	  Acetate	  on	  Non-­‐Propagating	  Contractions	  in	  Proximal	  
Colon	  
	   Following	  perfusion	  and	  distension	  using	  a	  solution	  of	  acetate	  in	  Krebs	  buffer,	  non-­‐propagations	  were	  quantified	  in	  the	  proximal	  colon.	  At	  all	  doses,	  acetate	  decreased	  non-­‐propagating	  contractions	  versus	  control.	  Data	  represent	  number	  of	  non-­‐propagating	  contractions	  per	  5	  min	  period.	  (n=3,	  Mean	  ±	  SEM)
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Figure	  18.	  Effect	  of	  Acetate	  on	  Non-­‐Propagating	  Contractions	  in	  Proximal	  
Colon	  
   
 64 
	  
	  
	  
	  
	  
	  
	  
Figure	  19.	  Overall	  Motility	  of	  Proximal	  Colon	  Following	  Acetate	  Treatment	  
	   Compared	  to	  control,	  an	  overall	  decrease	  in	  motility	  in	  the	  proximal	  colon	  was	  observed	  following	  luminal	  perfusion	  of	  acetate	  solution.	  Both	  propagations	  and	  non-­‐propagations	  decreased	  slightly	  with	  increasing	  concentration	  of	  acetate.
   
 65 
Figure	  19.	  Overall	  Motility	  of	  Proximal	  Colon	  Following	  Acetate	  Treatment	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Figure	  20.	  Mean	  Pellet	  Velocity	  Following	  Caudad	  Perfusion	  of	  30mM	  Aceate	  
	   Following	  perfusion	  of	  30mM	  acetate	  via	  a	  flexible	  catheter	  (PE	  10	  tubing)	  inserted	  in	  the	  caudad	  end	  of	  distal	  colon,	  pellet	  velocity	  was	  decreased	  compared	  to	  control	  velocity.	  Control	  velocities	  were	  1.8	  ±	  0.1	  mm/s	  and	  increased	  to	  0.95	  ±	 0.3	  mm/s	  following	  30mM	  acetate	  intraluminal	  perfusion.	  (n=2,	  Mean	  ±	  SEM)
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Figure	  20.	  Mean	  Pellet	  Velocity	  Following	  Caudad	  Perfusion	  of	  30mM	  Aceate	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C4)	  Response	  of	  Proximal	  Colon	  to	  Equimolar	  and	  Physiological	  Ratios	  of	  SCFAs	  	   Five	  proximal	  colons	  from	  five	  guinea	  pigs	  were	  used	  to	  determine	  the	  effect	  of	  mixtures	  of	  SCFAs	  on	  colonic	  motility.	  In	  two	  cases,	  an	  equimolar	  ratio	  (10mM	  acetate,	  10mM	  butyrate,	  and	  10mM	  propionate)	  was	  perfused	  into	  the	  colon	  first.	  Following	  a	  10-­‐minute	  wash	  with	  Krebs	  buffer,	  a	  second	  perfusion	  was	  done	  using	  an	  equivalent	  total	  of	  SCFAs	  at	  30mM	  but	  in	  a	  ratio	  more	  resembling	  physiological	  concentrations	  (15mM	  acetate,	  10mM	  butyrate,	  5mM	  propionate).	  In	  the	  remaining	  three	  trials,	  the	  order	  of	  mixture	  perfusion	  was	  reversed.	  
Neither	  full	  propagations	  nor	  short	  propagations	  behaved	  differently	  depending	  on	  the	  order	  of	  SCFA	  ratios	  used,	  and	  for	  this	  reason	  were	  counted	  together.	  Full	  propagations	  were	  no	  different	  from	  control	  to	  either	  mixture,	  with	  a	  baseline	  frequency	  of	  full	  propagations	  of	  2.0	  ±	  0.8	  per	  5-­‐minute	  period.	  (Figure	  
21A)	  In	  all	  cases,	  short	  propagations	  were	  completely	  abolished	  from	  control,	  which	  had	  a	  baseline	  frequency	  of	  short	  propagations	  of	  2.2	  ±	  0.7	  per	  5-­‐minute	  period.	  (Figure	  21B)	  
	   In	  the	  two	  trials	  that	  perfused	  equimolar	  amounts	  of	  SCFAs	  first,	  non-­‐propagations	  were	  abolished	  from	  a	  baseline	  frequency	  non-­‐propagations	  of	  37.5	  ±	  8.5	  per	  5-­‐minute	  period	  and	  did	  not	  return	  after	  a	  luminal	  washout	  with	  Krebs	  buffer	  followed	  by	  a	  physiological	  ratio	  of	  SCFAs.	  However,	  in	  the	  three	  trials	  that	  started	  with	  a	  physiological	  ratio	  of	  SCFAs	  and	  were	  followed	  by	  an	  equimolar	  ratio,	  there	  was	  no	  change	  in	  the	  frequency	  of	  non-­‐propagations	  from	  a	  baseline	  frequency	  of	  non-­‐propagations	  of	  70.7	  ±	  24	  per	  5-­‐minute	  period.	  (Figure	  22)	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   Four	  of	  the	  five	  segments	  showed	  an	  overall	  decrease	  in	  motility	  from	  control,	  which	  persisted	  throughout	  the	  remainder	  of	  the	  experiment.	  (Figure	  23)
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Figure	  21.	  Effects	  of	  Combinations	  of	  SCFAs	  on	  Propagating	  Contractions	  in	  
Proximal	  Colon	  
	   Whether	  SCFAs	  were	  combined	  in	  30mM	  total	  concentration	  in	  equal	  or	  physiological	  ratio	  (10mM	  acetate,	  propionate,	  and	  butyrate;	  or	  15mM	  acetate,	  10mM	  butyrate,	  and	  5mM	  propionate)	  there	  was	  no	  difference	  in	  their	  effect.	  (A)	  Full-­‐length	  propagations	  were	  not	  modified	  with	  either	  combination.	  (B)	  Short	  propagations	  were	  completely	  abolished	  with	  either	  combination.	  (C)	  Overall,	  a	  slight	  decrease	  in	  total	  propagations	  were	  observed	  versus	  control	  in	  both	  mixtures.	  (n=5,	  Mean	  ±	  SEM,	  p	  <	  0.05)
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Figure	  21.	  Effects	  of	  Combinations	  of	  SCFAs	  on	  Propagating	  Contractions	  in	  
Proximal	  Colon	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Figure	  22.	  Effect	  of	  Mixture	  Order	  on	  Non-­‐propagations	  in	  Proximal	  Colon	  
	   If	  an	  equimolar	  mixture	  of	  SCFAs	  was	  luminally	  perfused	  following	  control	  (n=2),	  it	  had	  a	  lasting	  inhibitory	  effect	  on	  non-­‐propagating	  contractions.	  However,	  if	  a	  physiological	  mixture	  of	  SCFAs	  was	  perfused	  following	  control	  (n=3),	  there	  was	  no	  significant	  effect	  on	  non-­‐propagations.	  (Mean	  ±	  SEM,	  p	  <	  0.05)
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Figure	  22.	  Effect	  of	  Mixture	  Order	  on	  Non-­‐propagations	  in	  Proximal	  Colon	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Figure	  23.	  Effect	  of	  SCFA	  mixtures	  on	  Overall	  Motility	  in	  Proximal	  Colon	  
	   Following	  perfusion	  of	  SCFA	  mixtures	  with	  a	  total	  concentration	  of	  30mM,	  an	  overall	  decrease	  in	  motility	  was	  observed.	  In	  trials	  which	  had	  the	  physiological	  first	  (pictured)	  non-­‐propagations	  still	  occurred,	  whereas	  non-­‐propagations	  were	  abolished	  with	  an	  initial	  perfusion	  of	  an	  equimolar	  mixture.
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Figure	  23.	  Effect	  of	  SCFA	  mixtures	  on	  overall	  motility	  in	  proximal	  colon	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4. Discussion 
 
 The series of experiments demonstrated that individual SCFAs have differential 
effects when perfused through the lumen of the proximal and distal colon of the guinea 
pig. In particular, butyrate at physiological concentrations of 10 or 30mM increased the 
frequency of propulsive contractions in the proximal colon and increased the velocity of 
artificial fecal pellets in the distal colon. Propionate at the same concentration decreased 
frequency of propulsive contractions in the proximal colon and decreased velocity of the 
artificial fecal pellets in the distal colon. Acetate showed a slight decreased in propulsive 
contractions in the proximal colon as well as pellet velocity in the distal colon. At 
equimolar and physiological mixtures, SCFAs showed decreased overall motility in the 
proximal colon. 
The effects observed throughout this study demonstrate differential effects that 
result from the presence of SCFAs in the lumen. Because sodium salts of acetate, 
propionate and butyrate were used, there was no shift in pH upon solvation of the SCFAs. 
However, an increase of 0.1M sodium was introduced to the solution and lumen at 
maximal doses of any SCFA solution. Therefore, control experiments were performed 
using standard Krebs buffer with 0.1M additional NaCl. This showed no difference in the 
motility of the proximal colon. The result of this control is further enhanced by the 
opposite effects observed by propionate and butyrate at the same concentration.  
In the ileum of many species, the presence of SCFAs result in strong caudal 
propagations. (59, 60, 61) The bacteria of the microbiome reside in the colon and cecum 
and receive undigested material that exits the ileum. Leakage of the cecocolonic contents 
   
 77 
back into the ileum would introduce bacteria to the small intestine. Small intestinal 
bacterial overgrowth (SIBO) is thought to contribute to IBS, though evidence from case to 
case is contradictory (62). It is likely that the contractile effect of SCFAs in the distal ileum 
are preventative to small intestinal colonization by colonic bacteria. 
In the cecum and colon, however, the microbiome is continuously present. Indeed, 
the SCFAs are the primary nutrient of colonocytes, and also play an osmotic role in water 
and ion transport. As contents are moved from the cecum to distal colon, they become 
more solid and are formed into feces to be excreted. The proximal colon is the primary site 
of water and ion absorption. Therefore, the movement of luminal contents should allow 
enough time for fermentation, and thus nutrient absorption and water and ion transport to 
occur. This can explain the slowing of overall motility with acetate, propionate, and both 
mixture ratios. It is also the reasons that pellets were used in the distal colon and fluid was 
used in the proximal colon. 
The overall decrease in motility following perfusion of the mixtures agrees with 
previous studies performed by Cherbut (19) which showed decreased frequency of spike 
bursts of muscle in rat colon following infusion of a physiological SCFA mixture. This 
decrease in spike bursts occurred in conjunction with an intravenous increase in PYY. 
PYY has been colocalized with enteroendocrine cells containing FFA2 (35), and thus gives 
a possible mechanism for SCFA induced decreases in motility. However, Cherbut also 
found that propionate and butyrate both decreased spike bursts, while butyrate increased 
the progression of colonic transit markers. This finding implies that spike bursts do not 
completely correlate to colonic transit. 
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PYY is a neuroendocrine mediator that slows gastric emptying and promotes 
digestion and nutrient absorption in the small intestine. It is present throughout the GI tract 
in enteroendocrine cells, but experiences its largest release following nutrients entering the 
ileum and chyme exiting into the colon. These events result in the mechanism of the ileal 
and colonic brakes and signal the end of a meal throughout the GI tract. (36) All SCFAs 
stimulate the release of PYY, as shown by Cherbut.  
PYY is similar to neuropeptide Y (NPY), another tyrosine containing peptide. 
These peptides, as well as pancreatic polypeptide (PP) are expressed by cell systems 
throughout the gut-brain axis and mediate the communication either exclusively within the 
GI tract (PYY and PP) or throughout the axis (NPY). (57) PYY and NPY both activate a 
family of receptors Y1-4 which are expressed throughout the GI epithelium as well as on 
enteric neurons. Y2, for example, is expressed primarily on intrinsic afferent neurons and 
secretomotor neurons within the submucosous and myenteric plexus (36). In particular, Y2 
has been colocalized on VIP containing motor neurons. This provides a possible 
explanation for the inhibitory effect seen with SCFA infusion in the colon. 
Combining this background knowledge with the present results, it seems possible 
that propionate stimulates the greatest release of PYY and results in the overall inhibition 
of colonic motility. Propionate also displays the greatest potency to FFA2/3 (34, 35). This 
could further explain how propionate could possibly facilitate the greatest PYY release.  
Soret (22) demonstrated that contraction of isolated circular muscle strips from the 
rat colon is augmented by butyrate when stimulated through electrical-field stimulation 
(EFS), and is inhibited by atropine. This effect is not seen when carbachol is used in place 
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of EFS, implying that butyrate influences the behavior of enteric neurons that are 
responsible for initiating contraction of the smooth muscle, rather than any direct effect on 
smooth muscle cells. This finding introduces the possibility that luminal perfusion of 
butyrate may be affecting enteric neurons that lie beyond the mucosa. It is possible that 
following excision, the mucosa of the guinea pig begins to die and allows luminal contents 
to pass into direct contact with the submocosal plexus. However, almost no mucosa was 
observed in the outflow bath following the experiments. Histological views of colonic 
cross-sections before and after the experiments would better inform this possibility. 
Acetate, propionate, and butyrate not only bind to FFA2 and FFA3, but are 
transported into colonocytes via monocarboxylate transporters (MCT1), some of which are 
sodium-coupled (SMCT1). (63) Recently, other MCTs have been attributed to intestinal 
epithelial transport. (64) MCTs have been shown in various cell types within the central 
nervous system. But this remains to be shown on enteric neurons (22). Soret’s results for 
butyrate on contraction of circular muscle show that the effect is actually occurring 
through the enteric neurons on the circular muscle cells. This provides a possible 
explanation for butyrate’s opposing effect to that of acetate and propionate on propagations 
and non-propagations. Additionally, this provides a possible explanation for the lack of 
disappearance of non-propagations in the physiological mixture. It is possible that butyrate 
increases release of transmitters from motorneurons closely associated with smooth muscle 
cells in the circular layer, while PYY release is increased by propionate and binds to 
receptors on the interneurons within the reflex. 
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In the physiological mixture, in which propionate is at its lowest concentration, it 
only partially blocks the local contractions (non-propagations) but is sufficient to decrease 
propagations which require coordination throughout the segment of tissue to initiate 
propagations. 
Grider (21) has previously demonstrated that acetate, propionate and butyrate all 
increase the ascending contraction and descending relaxation of the peristaltic reflex in a 
three-chambered flat-sheet preparation of rat distal colon.  The response was dose 
dependent increasing from 5-100mM. Release of 5-HT and CGRP were also increased 
several-fold following mucosal application of SCFAs. This increase in the peristaltic reflex 
is consistent with the present findings of butyrate but not for propionate or acetate. 
Colocalization of FFA2 or FFA3 with 5-HT has not been found in the mucosa of the GI 
tract. (35) However, FFA2 has been colocalized with 5-HT containing mast cells that 
reside just beneath the mucosal layer. (35, 32) It is possible that these mast cells are 
response for the release of 5-HT and thereby facilitate release of CGRP, which initiates the 
peristaltic reflex. Additionally, 5-HT containing mast cells have only been observed 
through immunoreactivity staining in the submucosa of mice. 5-HT containing mast cells 
have not been observed in the submucosa of humans (44). It is therefore possible that such 
differences exist between rodent species as well and thus explain the differences observed 
between rats and the guinea pigs used in the present study.  
To determine the downstream effects of SCFAs on colonic motility, several studies 
could be performed. Block of FFA2/3 either specifically or individually is at present not 
possible due to a lack of antagonists, however, pharmacological studies are showing 
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progress and it is likely several will be commercially available in the coming years (34, 35) 
Luminal perfusion of intracellular inhibitors downstream of FFA2/3 would be possible, but 
would interfere with too many accessory cellular processes to yield significant results. 
Luminal perfusion of antagonists for 5-HT receptors just beyond the mucosa could 
determine if the increases observed with butyrate are mediated through 5-HT initiation of 
the peristaltic reflex. The same experiment could also be performed with a Y2 receptor 
antagonist, which would block any effect that PYY release may have on colonic motility.  
Use of other species following the same experiments could also aid in determining the 
absolute effect of SCFAs on colonic motility. 
In summary, the present study demonstrated that individual SCFAs, which are the 
result of bacterial fermentation, have differential effects on contractile motility of the 
proximal and distal colon of the guinea pig. These effects do not differ from the proximal 
to distal colon, but do differ with SCFA chain length. 
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